HIV News and Research

RSS

University of North Carolina receives $8M grant to improve maternal and infant health

The University of North Carolina at Chapel Hill has received a five-year, $8 million grant from the Bill & Melinda Gates Foundation to improve maternal and infant health and save the lives of mothers and infants in Malawi by strengthening the President's Maternal Health and Safe Motherhood Initiative (SMI).

11 Jul 2013

IDSA and ASM collaborate to guide the best use of lab tests for diagnosis of infectious diseases

A new guide developed by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) will help physicians appropriately and accurately use laboratory tests for the diagnosis of infectious diseases. Laboratory test results drive approximately two-thirds of physicians' medical decisions.

11 Jul 2013

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Pfizer Inc. announced today the company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), received European approval for an expanded indication to include adults aged 18 to 49 years for active immunization for the prevention of invasive disease caused by vaccine-type Streptococcus pneumoniae (S. pneumoniae).

10 Jul 2013

Cancer immunotherapies promise to be a new tool in fight against cancer

Drugs that direct a cancer patient's immune system to eradicate her or his disease, known as cancer immunotherapies, promise to be a new tool in the fight against cancer. Since the Koch Institute's inception, exploring the close relationship between the immune system and cancer has been one of the Institute's priority research areas.

9 Jul 2013

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

8 Jul 2013

Seattle researchers map critical molecules that regulate inflammation during flu infection

The influenza virus' ability to mutate quickly has produced new, emerging strains that make drug discovery more critical than ever. For the first time, researchers at Seattle BioMed, along with collaborators at the University of California, San Diego School of Medicine, St. Jude Children's Research Hospital and the University of Washington, have mapped how critical molecules regulate both the induction and resolution of inflammation during flu infection.

6 Jul 2013

Data shows individualized regimens can help optimize prophylaxis treatment in hemophilia patients

Baxter International Inc. today announced data featuring ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method], a leading recombinant treatment available worldwide, during the 24th Annual Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Amsterdam, The Netherlands.

From Baxter International Inc. 5 Jul 2013

Collaborative research yields a wiring map on how TB responds to changes in environment

Despite decades of research on the bacterium that causes tuberculosis (TB), scientists have not had a comprehensive understanding of how the bacterium is wired to adapt to changing conditions in the host.

5 Jul 2013

Book provides new insight on one of the most common infectious diseases, Chlamydia

Chlamydiae are obligate intracellular bacteria that cause one of the most common sexually transmitted infectious diseases in the world. The infection disproportionately impacts women and the highest prevalence of infection is found in adolescents.

5 Jul 2013

Researchers find that hot flashes take heavier toll on quality of life in HIV-infected women

Women with HIV are living longer, so more are entering menopause. As they do, they suffer more severe hot flashes than women without HIV, and their hot flashes take a heavier toll on their quality of life and daily functioning, found researchers at Massachusetts General Hospital.

4 Jul 2013

Research shows lower daily dose of HIV drug therapy suppresses virus

Millions more people could get access to life-saving HIV drug therapy, following a landmark study led by Australian researchers based at the Kirby Institute at the University of New South Wales (UNSW).

4 Jul 2013

Key HIV drug prices continue to fall, but newer medicines still priced too high

International medical humanitarian organisation Médecins Sans Frontières today released its annual report Untangling the Web of ARV Price Reductions,at the International AIDS Society conference in Kuala Lumpur.

3 Jul 2013

NCKU implements two condom vending machines on campus

National Cheng Kung University (NCKU), southern Taiwan, implementing two condom vending machines, June 27, on campus makes it the first national university in Taiwan to promote safe sex and healthy lifestyles among the students.

3 Jul 2013

NIH awards nursing students of Wayne State University to gain unique insight about research fields

Eight Wayne State University undergraduate nursing students are gaining unique insight about the research field thanks to a $40,000 grant awarded to the university's College of Nursing and School of Medicine from the National Institute of Nursing Research of the National Institutes of Health.

3 Jul 2013

NIDA grants $3.3M to design vaccine conferring immunity to nicotine

A chemical component present in the nightshade family of plants is one of the world's most tenaciously addictive substances. It is the nicotine contained in tobacco and found in high concentrations in cigarettes. Smoking remains a global scourge; in the U.S. it is the leading source of preventable death.

3 Jul 2013

UH and Case Western Reserve University to develop diagnostic tests to determine HIV drug resistance

Case Western Reserve University has signed an exclusive worldwide licensing agreement granting University Hospitals Case Medical Center rights to a series of diagnostic tests to determine drug resistance and co-receptor tropism in human immunodeficiency virus.

2 Jul 2013

Viewpoints: A 'clever' fix for contraception coverage; Sanjay Gupta warns doctors to pay attention to health overhaul

Many nonprofit religious organizations have balked at having to insure their employees' birth control -- because they don't believe in artificial contraception -- under the Affordable Care Act. On Friday, the Obama administration announced a solution to this problem. The new health care law guarantees access to preventive services, and contraception falls, appropriately, into that category (Carla Hill, 6/28).

2 Jul 2013

EGPAF welcomes new HIV/AIDS treatment and prevention guidelines

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) welcomes the World Health Organization (WHO)'s new HIV/AIDS treatment and prevention guidelines. For the first time, the 2013 guidelines combine recommendations across the continuum of HIV care and prevention programs, including expanding treatment eligibility for HIV-positive pregnant women, mothers, and children.

2 Jul 2013

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

NanoViricides, Inc. announced today that it has submitted its letter of intent to file an Orphan Drug Application with the European Medicines Agency for DengueCide, its drug candidate for the treatment of dengue and dengue hemorrhagic fever.

1 Jul 2013

WHO's new HIV treatment guidelines call for immediate ART for HIV-infected children

The World Health Organization's new HIV treatment guidelines, released today at the 2013 International AIDS Society Conference, include new antiretroviral therapy recommendations for HIV-infected children, and will mean that more children will be on better treatments.

1 Jul 2013

HIV News and Research

University of North Carolina receives $8M grant to improve maternal and infant health

IDSA and ASM collaborate to guide the best use of lab tests for diagnosis of infectious diseases

Pfizer's Prevenar 13 receives European approval to include adults for prevention of invasive disease

Cancer immunotherapies promise to be a new tool in fight against cancer

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

Seattle researchers map critical molecules that regulate inflammation during flu infection

Data shows individualized regimens can help optimize prophylaxis treatment in hemophilia patients

Collaborative research yields a wiring map on how TB responds to changes in environment

Book provides new insight on one of the most common infectious diseases, Chlamydia

Researchers find that hot flashes take heavier toll on quality of life in HIV-infected women

Research shows lower daily dose of HIV drug therapy suppresses virus

Key HIV drug prices continue to fall, but newer medicines still priced too high

NCKU implements two condom vending machines on campus

NIH awards nursing students of Wayne State University to gain unique insight about research fields

NIDA grants $3.3M to design vaccine conferring immunity to nicotine

UH and Case Western Reserve University to develop diagnostic tests to determine HIV drug resistance

Viewpoints: A 'clever' fix for contraception coverage; Sanjay Gupta warns doctors to pay attention to health overhaul

EGPAF welcomes new HIV/AIDS treatment and prevention guidelines

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

WHO's new HIV treatment guidelines call for immediate ART for HIV-infected children

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News